1. Home
  2. ESRT vs STTK Comparison

ESRT vs STTK Comparison

Compare ESRT & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Empire State Realty Trust Inc.

ESRT

Empire State Realty Trust Inc.

N/A

Current Price

$4.72

Market Cap

836.1M

Sector

Real Estate

ML Signal

N/A

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

N/A

Current Price

$7.43

Market Cap

683.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ESRT
STTK
Founded
2011
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
836.1M
683.8M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
ESRT
STTK
Price
$4.72
$7.43
Analyst Decision
Hold
Buy
Analyst Count
3
7
Target Price
$6.35
$10.00
AVG Volume (30 Days)
1.9M
963.1K
Earning Date
04-29-2026
05-01-2026
Dividend Yield
2.49%
N/A
EPS Growth
N/A
53.02
EPS
N/A
N/A
Revenue
$768,270,000.00
$1,000,000.00
Revenue This Year
$4.26
N/A
Revenue Next Year
$1.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.05
N/A
52 Week Low
$4.61
$0.80
52 Week High
$8.07
$8.33

Technical Indicators

Market Signals
Indicator
ESRT
STTK
Relative Strength Index (RSI) 36.97 54.34
Support Level N/A $5.87
Resistance Level $5.85 $7.75
Average True Range (ATR) 0.18 0.48
MACD -0.03 -0.03
Stochastic Oscillator 13.41 50.00

Price Performance

Historical Comparison
ESRT
STTK

About ESRT Empire State Realty Trust Inc.

Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: